Home > Balance Sheet > NATCO PHARMA

NATCO PHARMA
Sundry Debtors

    Back to Balance Sheet
NATCO PHARMA is part of below Screeners ↓
Top Small Cap Stocks with Best Fundamentals
Top Undervalued Small Cap Stocks
COMMUNITY POLL
for NATCO PHARMA
Please provide your vote to see the results

NATCO PHARMA Last 5 Year Sundry Debtors History

[Consolidated]

Mar2024Mar2023Mar2022Mar2021Mar2020
Sundry Debtors ₹1,189 Cr₹856 Cr₹621 Cr₹413 Cr₹551 Cr

What is the latest Sundry Debtors ratio of NATCO PHARMA ?

The latest Sundry Debtors ratio of NATCO PHARMA is ₹1,189 Cr based on Mar2024 Consolidated results.
Year Sundry Debtors
Mar2024₹1,189 Cr
Mar2023₹856 Cr
Mar2022₹621 Cr
Mar2021₹413 Cr
Mar2020₹551 Cr

How is Sundry Debtors of NATCO PHARMA Trending?

Years Sundry Debtors % Change
Mar2024 ₹1,189 Cr
38.87
Mar2023 ₹856 Cr
37.95
Mar2022 ₹621 Cr
50.30
Mar2021 ₹413 Cr
-25.10
Mar2020 ₹551 Cr -

Compare Sundry Debtors of peers of NATCO PHARMA

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
NATCO PHARMA ₹15,823.5 Cr 4.5% 7.1% -11.6% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹433,032.0 Cr 0.9% 2.2% 23.9% Stock Analytics
DIVIS LABORATORIES ₹162,252.0 Cr 3.3% 4.7% 58% Stock Analytics
CIPLA ₹124,457.0 Cr 0.5% 2% 11.1% Stock Analytics
TORRENT PHARMACEUTICALS ₹112,425.0 Cr -0.4% 2.8% 24.2% Stock Analytics
DR REDDYS LABORATORIES ₹98,152.8 Cr -0.8% -0.4% 0.8% Stock Analytics


NATCO PHARMA Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
NATCO PHARMA

4.5%

7.1%

-11.6%

SENSEX

0.9%

3%

8.9%


You may also like the below Video Courses